Use of an Ang-(1-7) Receptor Agonist in Acute Lung Injury
With age-adjusted incidences of 86 per 100.000 person-years and overall mortality rates of about 43%, acute lung injury (ALI) and its most severe form, the acute respiratory distress syndrome (ARDS), remains a major cause of death in intensive care. So far, the only evident improvement for the survival of ARDS patients has been achieved by the implementation of minimal invasive ventilation strategies with low tidal volumes as compared to the previously used high tidal volumes. Ang-(1-7) or related agonists may represent a new and promising strategy for the treatment of ALI/ARDS. The present invention provides means and methods for a pharmacological intervention in the patho-physiologic events underlying ALI/ARDS.
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Ursula Haufe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
